Avenue Historical Cash Flow
| ATXI Stock | USD 2.01 0.00 0.00% |
Analysis of Avenue Therapeutics cash flow over time is an excellent tool to project Avenue Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 1.1 K or Other Non Cash Items of 294.5 K as it is a great indicator of Avenue Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Avenue Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avenue Therapeutics is a good buy for the upcoming year.
Avenue |
About Avenue Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Avenue balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Avenue's non-liquid assets can be easily converted into cash.
Avenue Therapeutics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Avenue Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Avenue Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.As of now, Avenue Therapeutics' Change To Account Receivables is increasing as compared to previous years. The Avenue Therapeutics' current Issuance Of Capital Stock is estimated to increase to about 7.9 M, while Sale Purchase Of Stock is projected to decrease to under 1.2 M.
Avenue Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Avenue Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avenue Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (895K) | 32.3M | 0.0 | (1.1M) | 1.2M | 1.2M | |
| Change In Cash | 6.1M | (5.6M) | 631K | 2.9M | (4.9M) | (4.7M) | |
| Free Cash Flow | (26.3M) | (5.6M) | (3.8M) | (7.6M) | (12.5M) | (13.1M) | |
| Change In Working Capital | (2.3M) | (172K) | (461K) | 408K | (290K) | (275.5K) | |
| Other Cashflows From Financing Activities | (2.7M) | (1M) | (663K) | 148K | 1K | 1.1K | |
| Other Non Cash Items | 61K | 939K | 909K | (5.1M) | 310K | 294.5K | |
| Total Cash From Operating Activities | (26.3M) | (4.6M) | (3.8M) | (7.6M) | (9.5M) | (9.9M) | |
| Change To Operating Activities | 1.0M | 57K | (84K) | (30K) | (27K) | (25.7K) | |
| Net Income | (25.9M) | (5.2M) | (3.7M) | (3.6M) | (10.4M) | (10.9M) | |
| Total Cash From Financing Activities | (895K) | 32.3M | 4.4M | 10.5M | 7.5M | 8.2M | |
| End Period Cash Flow | 8.7M | 3.1M | 3.8M | 6.7M | 1.8M | 1.7M | |
| Change To Netincome | 1.8M | 710K | 442K | (4.5M) | (4.0M) | (3.8M) | |
| Change To Liabilities | (2.2M) | (229K) | (377K) | 348K | 313.2K | 218.7K | |
| Stock Based Compensation | 1.8M | 710K | 442K | 649K | 906K | 923.3K | |
| Begin Period Cash Flow | 2.7M | 8.7M | 3.1M | 3.8M | 6.7M | 5.1M |
Currently Active Assets on Macroaxis
When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share 24.78 | Return On Assets (2.01) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.